Skip to main content

Nasdaq News

AbbVie Announces FDA Approval Of JUVMO For Parkinson's Disease

4 days 4 hours ago
(RTTNews) - AbbVie (ABBV) announced the FDA has approved JUVMO tablets as the first and only selective D1/D5 receptor agonist for the treatment of adults with Parkinson's disease. The approval is supported by the Phase 3 TEMPO program. AbbVie expects to make JUVMO available to pa
RTTNews

Stocks Settle Higher as Crude Prices Fall on US-Iran Deal Hopes

4 days 4 hours ago
The S&P 500 Index ($SPX ) (SPY ) closed up by +0.51% on Friday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.93%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.42%. December E-mini S&P futures (ESZ26 ) rose +0.47%, and December E-mini...
Barchart

Stocks Settle Higher as Crude Prices Fall on US-Iran Deal Hopes

4 days 4 hours ago
The S&P 500 Index ($SPX ) (SPY ) closed up by +0.51% on Friday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.93%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.42%. December E-mini S&P futures (ESZ26 ) rose +0.47%, and December E-mini...
Barchart
Checked
19 minutes 2 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed